A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer

• Tatiana Shaurova,
• Lingyue Yan,
• Yafei Su,
• Laurie James Rich,
• Vui King Vincent‐Chong,
• Hannah Calkins,
• Saraswati Pokharel,
• Martin Petkovich,
• Mukund Seshadri,
• Yun Wu,
• Pamela Anne Hershberger

Affiliations

Tatiana Shaurova

Department of Pharmacology and Therapeutics Roswell Park Comprehensive Cancer Center Buffalo New York USA

Lingyue Yan

Department of Biomedical Engineering University at Buffalo the State University of New York Buffalo New York USA

Yafei Su

Department of Biomedical Engineering University at Buffalo the State University of New York Buffalo New York USA

Laurie James Rich

Cell Stress and Biophysical Oncology Graduate Program Roswell Park Comprehensive Cancer Center Buffalo New York USA

Vui King Vincent‐Chong

Department of Oral Oncology Roswell Park Comprehensive Cancer Center Buffalo New York USA

Hannah Calkins

Department of Pharmacology and Therapeutics Roswell Park Comprehensive Cancer Center Buffalo New York USA

Saraswati Pokharel

Department of Pathology Roswell Park Comprehensive Cancer Center Buffalo New York USA

Martin Petkovich

Cancer Research Institute School of Medicine Queens University Kingston Ontario Canada

Mukund Seshadri

Department of Oral Oncology Roswell Park Comprehensive Cancer Center Buffalo New York USA

Yun Wu

Department of Biomedical Engineering University at Buffalo the State University of New York Buffalo New York USA

Pamela Anne Hershberger

Department of Pharmacology and Therapeutics Roswell Park Comprehensive Cancer Center Buffalo New York USA